M. J. Thomson

Publication List Details

Period

1995 - 1999

Number

14

Co-Authors

Hansen Type I disk disease at T1-2 in a Dachshund (1999)

Liptak, J. M., Watt, P. R., Thomson, M. J., Copeland, S. E., Galloway, A. M.

A 7-year-old Dachshund was presented with chronic left thoracic limb lameness and acute neurological deficits to the hind limbs following trauma. A lesion was suspected between C7 and T2 on the basis...

Ground-state Spectrum of Light-quark Mesons (1996)

Burden, C. J., Qian, Lu, Roberts, C. D., Tandy, P. C., Thomson, M. J.

A confining, Goldstone theorem preserving, separable Ansatz for the ladder kernel of the two-body Bethe-Salpeter equation is constructed from phenomenologically efficacious $u$, $d$ and $s$...

Electromagnetic Form Factors of Charged and Neutral Kaons (1995)

Burden, C. J., Roberts, C. D., Thomson, M. J.

The charged and neutral kaon form factors are calculated as a phenomenological application of the QCD Dyson-Schwinger equations. The results are compared with the pion form factor calculated in the...

Large neutrino asymmetries from neutrino oscillations (1995)

Foot, R., Thomson, M. J., Volkas, R. R.

We re-examine neutrino oscillations in the early universe. Contrary to previous studies, we show that large neutrino asymmetries can arise due to oscillations between ordinary neutrinos and sterile...

Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.

Sheehan, G J, Harding, G K, Haase, D A, Thomson, M J, Urias, B, Kennedy, J K, ...

We evaluated the benefits of prolonging norfloxacin therapy from 12 to 24 weeks for complicated urinary tract infection in a double-blind, randomized, placebo-controlled study. During the second 12...

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.

Haase, D A, Harding, G K, Thomson, M J, Kennedy, J K, Urias, B A, Ronald, A R

Forty-three women with acute, symptomatic urinary tract infections were randomized to receive either norfloxacin (400 mg) twice daily or trimethoprim-sulfamethoxazole (160-800 mg) twice daily for 10...

Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection.

Sheehan, G J, Harding, G K, Haase, D A, Thomson, M J, Urias, B, Kennedy, J K, ...

We evaluated the benefits of prolonging norfloxacin therapy from 12 to 24 weeks for complicated urinary tract infection in a double-blind, randomized, placebo-controlled study. During the second 12...

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.

Haase, D A, Harding, G K, Thomson, M J, Kennedy, J K, Urias, B A, Ronald, A R

Forty-three women with acute, symptomatic urinary tract infections were randomized to receive either norfloxacin (400 mg) twice daily or trimethoprim-sulfamethoxazole (160-800 mg) twice daily for 10...